TRPA1 as a drug target—promise and challengesJun Chen(Gene Therapy Laboratory), David H. HackosNaunyn-Schmiedeberg s Archives of PharmacologyFebruary 2, 201510.1007/s00210-015-1088-3Cited by 156SaveCiteExport RISWatch citationsRelated PapersGluN2A NMDA Receptor Enhancement Improves Brain Oscillations, Synchrony, and Cognitive Functions in Dravet Syndrome and Alzheimer’s Disease Models|Cell Reports|2020|91